Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Research Article
  • Published:

The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs

Abstract

Interleukin-12 (IL-12) plays a key role in promoting T helper 1 (Th1) responses and subsequent cell-mediated immunity. Given the role of cytokines in the pathogenesis of psychiatric disorders, the dysregulation of IL-12 in these illnesses would be expected. We measured the plasma levels of IL-12 in 102 psychiatric patients (43 schizophrenia, 34 major depression and 25 bipolar disorder) and 85 normal controls. In addition, IL-12 levels of the patients were measured after an 8-week treatment to assess whether the levels were affected by medication. The IL-12 levels of the patient group with major depression were significantly higher than that of the control group, whereas no differences were found among the other groups. IL-12 values of the three patient groups decreased significantly after 8 weeks of treatment. These findings support the hypothesis that activation of the inflammatory response system and in particular of Th-1-like cells, is involved in the pathophysiology of major depression and that repeated administration of antidepressive and antipsychotic drugs may suppress IL-12 plasma concentrations in psychiatric patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Smith RS . Is schizophrenia caused by excessive production of interleukin-2 and interleukin-2 receptors by gastrointestinal lymphocyte? Med Hypotheses 1991 34: 225–229

    Article  CAS  Google Scholar 

  2. Smith RS, Maes M . The macrophage-T lymphocyte theory of schizophrenia: additional evidence Med Hypotheses 1995 45: 135–141

    Article  CAS  Google Scholar 

  3. Maes M, Smith RS, Scharpe S . The monocyte-T-lymphocyte hypothesis of major depression Psychoneuroendocrinology 1995 20: 116–120

    Google Scholar 

  4. Maes M, Bosmans E, Meltzer H, Scharpe S, Suy E . Interleukin-1®: a putative mediator of HPA axis hyperactivity in major depression? Am J Psychiatry 1993 150: 1189–1193

    Article  CAS  Google Scholar 

  5. Maes M . Evidence for an immune response in major depression: a review and hypothesis Prog NeuroPsychopharmacol Biol Psychiatry 1995 19: 11–38

    Article  CAS  Google Scholar 

  6. Muller N, Riedel M, Ackenheil M, Schwarz MJ . The role of immune function in schizophrenia: an overview Eur Arch Psychiatry Clin Neurosci 1999 249: 62–68

    Article  Google Scholar 

  7. Wilke I, Arolt V, Rothermundt M, Weitzsch CH, Hornberg M, Kirchner H . Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients Eur Arch Psychiatry Clin Neurosci 1996 246: 279–284

    Article  CAS  Google Scholar 

  8. Ganguli R, Yang Z, Shurin G, Chengappa KNR, Brar JS, Gubbi AV et al. Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness Psychiatry Res 1994 51: 1–10

    Article  CAS  Google Scholar 

  9. Frommberger UH, Bauer J, Haselbauer P, Fraulin A, Riemann D, Berger M . Interleukin-6 (IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission Eur Arch Psychiatry Clin Neurosci 1997 247: 228–233

    Article  CAS  Google Scholar 

  10. van Kammen DP, McAllister-Sistilli CG, Kelley ME, Gurklis JA, Yao JK . Elevated interleukin-6 in schizophrenia Psychiatry Res 1999 87: 129–136

    Article  CAS  Google Scholar 

  11. Tananka KF, Shintani F, Fujii Y, Yagi G, Asai M . Serum interleukin-18 levels are elevated in schizophrenia Psychiatry Res 2000 96: 75–80

    Article  Google Scholar 

  12. Ganguli R, Brar JS, Chengappa KNR, Deleo M, Yang ZW, Shurin G et al. Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients Arch Gen Psychiatry 1995 52: 668–672

    Article  CAS  Google Scholar 

  13. Kim YK, Lee MS, Suh KY . Decreased IL-2 production in Korean schizophrenic patients Biol Psychiatry 1998 43: 701–704

    Article  CAS  Google Scholar 

  14. Arolt V, Rothermundt M, Wandinger KP, Kirchner H . Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment Mol Psychiatry 2000 5: 150–158

    Article  CAS  Google Scholar 

  15. Rothermundt M, Arolt V, Weitzsch C, Eckhoff D, Kirchner H . Immunological dysfunction in schizophrenia: a systematic approach Neuropsychobiology 1998 37: 186–193

    Article  CAS  Google Scholar 

  16. Mittleman BB, Castellanos FX, Jacobsen LK, Rapoport JL, Swedo SE, Shearer GM . Cerebrospinal fluid cytokines in pediatric neuro-psychiatric disease J Immunol 1997 159: 2994–2999

    CAS  PubMed  Google Scholar 

  17. van Kammen DP, McAllister-Sistilli CG, Kelley ME . Relationship between immune and behavioral measures in schizophrenia In: Wieselmann G (ed) Current Update in Psychoimmunology Springer Verlag Wien: NY 1997 pp 51–55

    Chapter  Google Scholar 

  18. Cazzullo CL, Scarone S, Grassi B, Vismara C, Trabattoni D, Clerici M et al. Cytokine production in chronic schizophrenia patients with or without paranoid behavior Prog NeuroPsychoPharmacol Biol Psychiatry 1998 22: 947–957

    Article  CAS  Google Scholar 

  19. Kim YK, Kim L, Lee MS . Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics Schizophr Res 2000 44: 165–175

    Article  CAS  Google Scholar 

  20. Licinio J, Seibyl JP, Altemus M, Charney DS, Krystal JH . Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients Am J Psychiatry 1993 150: 1408–1410

    Article  CAS  Google Scholar 

  21. McAllister CG, van Kammen DP, Rehn TJ, Miller AL, Gurklis J, Kelley ME et al. Increases in CSF levels of IL-2 in schizophrenia: effects of recurrence of psychosis and medication status Am J Psychiatry 1995 152: 1291–1297

    Article  CAS  Google Scholar 

  22. Cazzullo CL, Sacchetti E, Galluzzo A, Panariello A, Colombo F, Zagliani A et al. Cytokine profiles in drug-naive schizophrenic patients Schizophr Res 2001 47: 293–298

    Article  CAS  Google Scholar 

  23. Maes M . Major depression and activation of the inflammatory response system In: Dantzer R et al (eds) Cytokines, Stress and Depression Plenum: New York 1999 pp 1–24

    Google Scholar 

  24. Connor TJ, Leonard BE . Depression, stress and immunological activation: the role of cytokines in depressive disorders Life Sci 1998 62: 583–606

    Article  CAS  Google Scholar 

  25. Licinio J, Wong ML . The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection Mol Psychiatry 1999 4: 317–327

    Article  CAS  Google Scholar 

  26. Dantzer R, Wollman E, Vitkovic L, Yirmiya R . Cytokines and depression: fortuitous or causative association? Mol Psychiatry 1999 4: 328–332

    Article  CAS  Google Scholar 

  27. Mikova O, Yakimova R, Bosmans E, Kenis G, Maes M . Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis Eur Neuropsychopharmacol 2001 11: 203–208

    Article  CAS  Google Scholar 

  28. Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY . Interleukin-2 and interlkin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers J Psychatr Res 1995 29: 141–152

    Article  CAS  Google Scholar 

  29. Rapaport MH, Guylai L, Whybrow P . Immune parameters in rapid cycling bipolar patients before and after lithium treatment J Psychiatry Res 1999 33: 335–340

    Article  CAS  Google Scholar 

  30. Tsai SY, Chen KP, Yang YY, Chen CC, Lee JC, Singh VK et al. Activation of indices of cell-mediated immunity in bipolar mania Biol Psychiatry 1999 45: 989–994

    Article  CAS  Google Scholar 

  31. Maes M, Delange J, Ranjan R, Meltzer HY, Desnyder R, Cooremans W et al. Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs Psychiatry Res 1997 66: 1–11

    Article  CAS  Google Scholar 

  32. Leykin I, Mayer R, Shinitzky M . Short and long term immunosuppressive effects of clozapine and haloperidol Immunopharmacology 1997 37: 75–86

    Article  CAS  Google Scholar 

  33. Maes M, Bosmans E, Ranjan R, Vandoolaeghe E, Meltzer HY, De Ley M et al. Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs Schizophr Res 1996 21: 39–50

    Article  CAS  Google Scholar 

  34. Maes M, Bosman E, Kenis G, De Jongh R, Smith RS, Meltzer HY . In vivo immunomodulatory effects of clozapine in schizophrenia Schizophr Res 1997 26: 221–225

    Article  CAS  Google Scholar 

  35. Maes M, Song C, Lin AH, Bonaccorso S, Kenis G, DeJongh R et al. Negative immunoregulatory effects of antidepressants: inhibition of interferon-© and stimulation of interleukin-10 secretion Neuropsychopharmacology 1999 20: 370–379

    Article  CAS  Google Scholar 

  36. Gately MK, Renzetti LM, Magram J, Stern AS, Adorini L, Gubler U et al. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses Annu Rev Immunol 1998 16: 495–521

    Article  CAS  Google Scholar 

  37. Stern AS, Magram J, Presky DH . Interlukin-12: an integral cytokine immune response Life Sci 1996 58: 639–654

    Article  CAS  Google Scholar 

  38. Trinchieri G . Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity Annu Rev Immunol 1995 13: 251–276

    Article  CAS  Google Scholar 

  39. Trinchieri G . Immunobiology of interleukin-12 Immunol Res 1998 17: 269–278

    Article  CAS  Google Scholar 

  40. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn) American Psychiatric Press: Washington DC 1994

  41. First MB, Gibbon M, Spitzer RL, Williams JBW . Structural Clinical Interview for DSM-IV Research Version Biometric Research Department, New York Psychiatric Institute: New York 1998

    Google Scholar 

  42. Overall JE, Gorham DR . The brief psychiatric rating scale Psychol Rep 1962 10: 799–812

    Article  Google Scholar 

  43. Hamilton M . A rating scale for depression J Neurol Neurosurg Psychiatry 1960 23: 56–62

    Article  CAS  Google Scholar 

  44. Young RC, Biggs JT, Ziegler VE, Meyer DA . A rating scale for mania: reliability, validity and sensitivity Br J Psychiatry 1978 133: 429–435

    Article  CAS  Google Scholar 

  45. Muller N, Ackenheil M . Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders Prog NeuroPsychopharmacol Biol Psychiatry 1998 22: 1–33

    Article  CAS  Google Scholar 

  46. McAdams C, Leonard BE . Neutrophil and monocyte phagocytosis in depressed patients Prog NeuroPsychopharmacol Biol Psychiatry 1993 17: 971–984

    Article  CAS  Google Scholar 

  47. Schwarz MJ, Ackenheil M, Riedel M, Muller N . Blood-CSF barrier impairment as indicator for an immune process in schizophrenia Neurosci Lett 1998 253: 201–203

    Article  CAS  Google Scholar 

  48. Lin A, Kenis G, Bignotti S, Tura GJB, DeJong R, Bosmans E et al. The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6 Schizophr Res 1998 32: 9–15

    Article  CAS  Google Scholar 

  49. Sluzewska A, Rybakowski JK, Laciak M, Mackiewicz A, Sobieska M, Wiktorowicz K . Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine Ann NY Acad Sci 1995 762: 474–476

    Article  CAS  Google Scholar 

  50. Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H . Cytokine production and serum proteins in depression Scand J Immunol 1995 41: 535–538

    Article  Google Scholar 

  51. Kubera M, Lin AH, Kenis G, Bosmans E, van Bockstaele D, Maes M . Anti-inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio J Clin Psychopharmacol 2001 21: 199–206

    Article  CAS  Google Scholar 

  52. Song C, Lin Ah, Kenis G, Bosmans E, Maes M . Immunosuppressive effects of clozapine and haloperidol: enhanced production of the interleukin-1 receptor antagonist Schizophr Res 2000 42: 157–164

    Article  CAS  Google Scholar 

  53. Maes M, Chiavetto LB, Bignotti S, Tura GJB, Pioli R, Boin F et al. Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics Eur Neuropsychopharmacol 2000 10: 119–124

    Article  CAS  Google Scholar 

  54. Maes M, Meltzer HY, Bosmans E . Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine Acta Psychiatr Scand 1994 89: 346–351

    Article  CAS  Google Scholar 

  55. Pollmacher T, Hinze-Selch D, Mullington J . Effects of clozapine on plasma cytokine and soluble cytokine receptor levels J Clin Psychopharmacol 1996 16: 403–409

    Article  CAS  Google Scholar 

  56. Nikkila HV, Muller K, Ahokas A, Miettien K, Rimon R, Andersson LC . Accumulation of macrophages in the CSF of schizophrenic patients during acute psychotic episodes Am J Psychiatry 1999 156: 1725–1729

    CAS  PubMed  Google Scholar 

  57. Sluzewska A, Sobieska M, Rybakowski JK . Changes in acute phase proteins during lithium potentiation of antidepressants in refractory depression Neuropsychobiology 1997 35: 123–127

    Article  CAS  Google Scholar 

  58. Rapaport MH, Manji HK . The effects of lithium on ex vivo cytokine production Biol Psychiatry 2001 50: 217–224

    Article  CAS  Google Scholar 

  59. Haack M, Hinze-Selch D, Fenzel T, Kraus T, Kuhn M, Schuld A et al. Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis J Psychiatric Res 1999 33: 407–418

    Article  CAS  Google Scholar 

  60. Riches P, Gooding R, Millar BC, Rowbottom AW . Influence of collection and separation of blood samples on plasma IL-1, IL-6 and TNF-α concentrations J Immunol Meth 1992 153: 125–131

    Article  CAS  Google Scholar 

  61. De Jongh R, Vranken J, Vundelinckx G, Bosmans E, Maes M, Heylen R . The effects of anticoagulation and processing on assays of IL-6, sIL-6R, sIL-2R and soluble transferrin receptor Cytokine 1997 9: 696–701

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank Professor Hae-Hiang Song in the Department of Biostatistics, Catholic Medical College for her assistance in data analysis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, YK., Suh, IB., Kim, H. et al. The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs. Mol Psychiatry 7, 1107–1114 (2002). https://doi.org/10.1038/sj.mp.4001084

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4001084

Keywords

This article is cited by

Search

Quick links